Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5276
Ultralife
ULBI
$101M
| $260 | ﹤0.01% |
29
-6,981
| -100% | -$41.4K |
2023 Q3
7 quarters
|
|
5277
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.08B
| $257 | ﹤0.01% |
+11
| New | +$242 |
2025 Q2
0 quarters
|
|
5278
Oncolytics Biotech
ONCY
$71.8M
| $254 | ﹤0.01% |
+333
| New | +$176 |
2025 Q2
0 quarters
|
|
5279
My Size
MYSZ
$802K
| $246 | ﹤0.01% |
25
| – | – |
2024 Q3
3 quarters
|
|
5280
TherapeuticsMD
TXMD
$22.3M
| $235 | ﹤0.01% |
+203
| New | +$246 |
2025 Q2
0 quarters
|
|
5281
DELISTED
Kezar Life Sciences
KZR
| $234 | ﹤0.01% |
51
| – | – |
2018 Q3
27 quarters
|
|
5282
Beeline Holdings
BLNE
$23.1M
| $231 | ﹤0.01% |
+156
| New | +$191 |
2025 Q2
0 quarters
|
|
5283
DELISTED
Associated Capital Group
AC
| $225 | ﹤0.01% |
6
| – | – |
2017 Q4
30 quarters
|
|
5284
Renaissance IPO ETF
IPO
$143M
| $225 | ﹤0.01% |
+5
| New | +$204 |
2025 Q2
0 quarters
|
|
5285
VanEck Agribusiness ETF
MOO
$1.14B
| $221 | ﹤0.01% |
3
| – | – |
2013 Q2
48 quarters
|
|
5286
Namib Minerals
NAMM
$55.9M
| $212 | ﹤0.01% |
+28
| New | +$447 |
2025 Q2
0 quarters
|
|
5287
AEON Biopharma
AEON
$12.1M
| $207 | ﹤0.01% |
+272
| New | +$156 |
2025 Q2
0 quarters
|
|
5288
Avantis Emerging Markets Equity ETF
AVEM
$27.3B
| $206 | ﹤0.01% |
+3
| New | +$189 |
2025 Q2
0 quarters
|
|
5289
System1
SST
$19.4M
| $205 | ﹤0.01% |
37
-1,747
| -98% | -$7.75K |
2023 Q1
9 quarters
|
|
5290
DELISTED
Northann Corp
NCL
| $204 | ﹤0.01% |
+159
| New | +$539 |
2025 Q2
0 quarters
|
|
5291
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.66B
| $203 | ﹤0.01% |
+4
| New | +$202 |
2025 Q2
0 quarters
|
|
|
BGM
5292
BGM Group Ltd
BGM
$115M
| $191 | ﹤0.01% |
+1
| New | +$363 |
2025 Q2
0 quarters
|
|
5293
Caesarstone
CSTE
$93.4M
| $189 | ﹤0.01% |
96
-14,336
| -99% | -$32.4K |
2023 Q2
8 quarters
|
|
5294
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.5B
| $187 | ﹤0.01% |
+9
| New | +$187 |
2025 Q2
0 quarters
|
|
5295
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
| $187 | ﹤0.01% |
+8
| New | +$187 |
2025 Q2
0 quarters
|
|
5296
DELISTED
ZyVersa Therapeutics
ZVSA
| $186 | ﹤0.01% |
+274
| New | +$179 |
2025 Q2
0 quarters
|
|
5297
Collective Mining Ltd
CNL
$1.04B
| $186 | ﹤0.01% |
+17
| New | +$172 |
2025 Q2
0 quarters
|
|
5298
New Mountain Finance
NMFC
$651M
| $179 | ﹤0.01% |
17
-10,933
| -100% | -$113K |
2013 Q2
48 quarters
|
|
5299
DELISTED
FiscalNote
NOTE
| $179 | ﹤0.01% |
28
-4,381
| -99% | -$32.8K |
2023 Q2
8 quarters
|
|
5300
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $177 | ﹤0.01% |
20
| – | – |
2013 Q2
48 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.